Position in PBYI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,884,166
-$4,557,180 QoQ
Shares Held
602,240
-59.2% QoQ
Ownership
1.17%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 160 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PBYI Over Time
Shares Held
Position Value (USD)
Derivatives in PBYI
reported options exposure · as of Mar 31, 2024CallValue
$663,560
CallShares
125,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,631,421,099 across 322 Biotechnology names. PBYI ranks #167 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | 1,491,404 | $197,954,052 | |||
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in PBYI
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,884,166 | 602,240 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $9,441,346 | 1,477,519 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $98,853 | 16,614 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $560,911 | 105,633 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,147,708 | 334,609 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,100,174 | 1,385,194 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,777,084 | 1,894,126 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,346,264 | 2,880,888 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,309,857 | 3,162,533 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $16,787,553 | 3,167,463 | Shares | Sole | 2024-05-15 | |
| 2024-03-31 | $663,560 | 125,200 | Call | Sole | 2024-05-15 | |
| 2023-12-31 | $13,701,198 | 3,164,249 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,109,207 | 3,083,349 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $526,000 | 200,000 | Call | Sole | 2023-11-14 | |
| 2023-06-30 | $931,214 | 263,800 | Call | Sole | 2023-08-14 | |
| 2023-06-30 | $9,906,076 | 2,806,254 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $9,226,230 | 2,985,835 | Shares | Sole | 2023-05-15 | |
| 2023-03-31 | $767,556 | 248,400 | Call | Sole | 2023-05-15 | |
| 2022-12-31 | $11,323,341 | 2,676,913 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $518,082 | 218,600 | Call | Sole | 2022-11-14 | |
| 2022-09-30 | $6,618,341 | 2,792,549 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,317,435 | 2,216,644 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,505,624 | 1,911,675 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,190,964 | 1,707,554 | Shares | Sole | 2022-02-14 | |
| 2021-12-31 | $608,000 | 200,000 | Call | Sole | 2022-02-14 | |
| 2021-09-30 | $11,684,162 | 1,666,785 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $6,028,092 | 656,655 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $7,555,842 | 777,350 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $7,066,062 | 688,700 | Shares | Sole | 2021-02-16 | |
| 2020-12-31 | $1,026,000 | 100,000 | Call | Sole | 2021-02-16 | |
| 2020-09-30 | $8,933,080 | 885,340 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $12,225,837 | 1,172,180 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $16,439,643 | 1,947,825 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||